Treatment patterns and clinical outcomes of newly diagnosed early-stage and locally advanced triple negative breast cancer (TNBC): A retrospective cohort analysis of national real-world data in England.

被引：0
|
作者：
Barham, Manpreet
Ntais, Dionysios
Macey, Karen
Murray, Kirsty
Castillo, Catherine
Ford, Alexander
Patel, Amisha
Holbrook, Tim
机构：
[1] Merck Sharp & Dohme Ltd, London, England
[2] Adelphi Real World, Bollington, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12577
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Treatment patterns and clinical outcomes of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): A retrospective cohort analysis of national real-world data in England
    Black, Chris M.
    Kong, Anthony
    Chiu, Gavin
    Bolodeoku, John
    Massey, Olivia
    Patel, Amisha
    Ford, Alexander
    Holbrook, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Real-world treatment patterns and effectiveness outcomes in patients with early-stage triple-negative breast cancer
    Haiderali, Amin
    Rhodes, Whitney C.
    Gautam, Santosh
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    FUTURE ONCOLOGY, 2021, 17 (29) : 3819 - 3831
  • [3] Patient characteristics and treatment patterns of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): A retrospective cohort analysis of real-world data in England
    Kong, A.
    Chiu, G.
    Shah, S. R.
    Bolodeoku, J.
    Casey, C. S.
    Massey, O.
    Patel, A.
    Black, C. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S855 - S855
  • [4] Real-World Outcomes with the KEYNOTE-522 Regimen in Early-Stage Triple-Negative Breast Cancer
    Casey Connors
    Stephanie A. Valente
    Ayat ElSherif
    Paula Escobar
    Anna Chichura
    Lauren Kopicky
    Erin Roesch
    Julie Ritner
    Patrick McIntire
    Yueqi Wu
    Chao Tu
    Julie E. Lang
    Annals of Surgical Oncology, 2025, 32 (2) : 912 - 921
  • [5] Real-world outcomes in patients receiving neoadjuvant chemotherapy for early-stage triple-negative breast cancer
    Rhodes, Whitney C.
    Gautam, Santosh
    Haiderali, Amin
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    CANCER RESEARCH, 2020, 80 (04)
  • [6] Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast Cancer
    Jacobson, Anne
    ONCOLOGIST, 2022, 27 : S17 - S18
  • [7] Patient characteristics and real-world treatment patterns in patients with early-stage triple-negative breast cancer receiving neoadjuvant chemotherapy
    Rhodes, Whitney C.
    Gautam, Santosh
    Haiderali, Amin
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort
    Grinda, Thomas
    Antoine, Alison
    Jacot, William
    Cottu, Paul-Henri
    Rouge, Thibault de la Motte
    Frenel, Jean-Sebastien
    Mailliez, Audrey
    Dalenc, Florence
    Goncalves, Anthony
    Clatot, Florian
    Reynier, Marie-Ange Mouret
    Levy, Christelle
    Ferrero, Jean-Marc
    Desmoulins, Isabelle
    Uwer, Lionel
    Petit, Thierry
    Jouannaud, Christelle
    Arnedos, Monica
    Chevrot, Michael
    Courtinard, Coralie
    Tredan, Olivier
    Brain, Etienne
    Perol, David
    Pistilli, Barbara
    Delaloge, Suzette
    EUROPEAN JOURNAL OF CANCER, 2023, 189
  • [9] Understanding real-world treatment and outcomes in patients diagnosed with metastatic triple negative breast cancer (mTNBC).
    Skinner, Karen E.
    Walker, Mark S.
    Haiderali, Amin
    Schwartzberg, Lee Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Real world outcomes of 2,339 patients with early-stage triple-negative breast cancer (TNBC) treated in British Columbia.
    Lucas, Mairi
    Chia, Stephen K. L.
    Speers, Caroline
    Lohrisch, Caroline A.
    Nichol, Alan
    Mitri, Zahi Ibrahim
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345